Our Mission

Pharmacy Times^® Clinical Forum events are roundtable discussions in specific therapeutic areas led by specialized practitioners and designed to share their real-world experiences and best practices. Pharmacy Times recaps discussions and creates articles and content to be featured in Pharmacy Times print publications and on pharmacytimes.com. 

With the goal of advancing clinical outcomes and improving patient care, Pharmacy Times offers the latest news and insights for the pharmacy professional, along with solutions that impact the everyday practice of pharmacy. Our family of print publications, digital resources, and live events such as Clinical Forum discussions offer countless opportunities for expanding and sharing knowledge among pharmacy professionals.

Meeting Objectives:

• Discuss molecular testing workflows for KMT2A rearrangements and NPM1 mutations to identify patients with relapsed/refractory AML who may be eligible for menin inhibitor therapy

• Compare label-specific recommendations between revumenib and ziftomenib regarding differentiation syndrome, QTc monitoring, and drug interactions to build effective monitoring and counseling protocols.

• Implement strategies for starting and maintaining therapy on menin inhibitors across sites of care, including prior authorization and financial navigations.

Engaging with peers on scientific advancements, innovative treatment protocols, and effective patient management approaches.

Discovering implementation strategies from leading institutions and centers of excellence that have transformed patient outcomes.

Building valuable and professional relationships with fellow specialists that extend beyond the event.

“It was very helpful to echo everyone’s thoughts and realize we have local colleagues practicing safely in similar ways. I can’t think of another forum where this happens.”

— Lowena Tam, PharmD, BCPS 

Northshore University Hospital Clinical

“The interactive format encouraged meaningful exchange of perspectives. In a rapidly evolving oncology landscape, these conversations are valuable.”

— Tammy McClellan, PharmD
Riverside Healthcare